The lung in the immunocompromised patient. Infectious complications. Part 1

Respiration

Volumn 66, Issue 2, 1999, Pages 95-109

  Baughman, Robert P ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CLINICAL FEATURE; HUMAN; IMMUNE DEFICIENCY; INFECTIOUS COMPLICATION; LUNG; LUNG INFECTION; MORBIDITY; MORTALITY; MYCOBACTERIOSIS; MYCOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW;

EID: 0032904168     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029349     Document Type: Review

References (179)

1. Niederman MS, Bass JB Jr. Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL: Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993;148:1418-1426.
2. Olsson M, Elvin K, Lofdahl S, Linder E: Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol 1993; 31:221-226.
3. Baughman RP: Use of bronchoscopy in the diagnosis of infection in the immunocompromised host. Thorax 1994;49:3-7.
4. Stover DE, Zaman MB, Hajdu SI, Lange M, Gold J, Armstrong D: Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunocompromised host. Ann Intern Med 1984;101:1-7.
5. Ekdahl K, Eriksson L, Rollof J, Miorner H, Griph H, Lofgren B: Bronchoscopic diagnosis of pulmonary infections in a heterogeneous, nonselected group of patients. Chest 1993;103: 1743-1748.
6. Djamin RS, Drent M, Schreurs AJ, Groen EA, Wagenaar SS: Diagnosis of Pneumocystis carinii pneumonia in HIV-positive patients. Bronchoalveolar lavage vs. bronchial brushing. Acta Cytol 1998;42:933-938.
7. Metersky ML, HarrellJH, IA, MoserKM: Lack of utility of bronchial brush biopsy in patients infected with the human immunodeficiency virus. Chest 1992;101:680-683.
8. Xaubet A, Torres A, Marco F, Puig-de la Bellacasa J, Faus R, Agusti-Vidal A: Pulmonary infiltrates in immunocompromised patients. Diagnostic value of telescoping plugged catheter and bronchoalveolar lavage. Chest 1989;95: 130-135.
9. Ferrer M, Torres A: Xaubet A, Puig de la Bellacasa J, Agusti C, Gonzalez J, de Celis R, Jimenez de Anta MT: Diagnostic value of telescoping plugged catheters in HIV-infected patients with pulmonary infiltrates. Chest 1992;102:76-83.
10. Broaddus C, Dake MD, Stulbarg MS, Blumenfeld LV, Hadley K, Golden JA, Hopewell PC: Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:747-752.
11. Baughman RP, Dohn MN, Frame PT: The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994;97:515-522.
12. Huang L, Hecht FM, Stansell JD, Montanti R. Hadley WK, Hopewell PC: Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Is early bronchoscopy useful? Am J Respir Crit Care Med 1995; 151:1866-1871.
13. Sternberg RI, Baughman RP, Dohn MN, First MR: Utility of bronchoalveolar lavage in assessing pneumonia in immunosuppressed renal transplant recipients. Am J Med 1993;95:358-364.
14. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG: Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974;80:83-93.
15. Bourbigot B, Bensoussan T, Garo B, Islam MS, Hardy E, Moal MC, Garre M: CD4 T-lymphocyte counts as predictors of pneumonia after kidney transplantation. Transplant Proc 1993; 25:1491-1492.
16. Dummer JS: Pneumocystis carinii infections in transplant recipients. Semin Respir Infect 1990;5:50-57.
17. Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ: Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol Dial Transplant 1995;10:1194-1197.
18. Talseth T, Holdaas H, Albrechtsen D, Berg KJ, Fauchald P, Naalsund A, Nordal KP, Skar AG, Sodal G, Flatmark A: Increasing incidence of Pneumocystis carinii pneumonia in renal transplant patients. Transplant Proc 1988;20:400-401.
19. Gryzan S, Paradis IL, Zeevi A, Duquesnoy RJ, Dummer JS, Griffith BP, Hardesty RL, Trento A, Nalesnik MA, Dauber JH: Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988;137:1268-1274.
20. Masur H, Michellis MA, Greene JB. An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestations of cellularimmune dysfunction. N Engl J Med 1981;305:1431-1438.
21. Friedman-Kien A, Laubenstein L, Marmor M, Hymes K, Green J, Ragaz A, Gottleib J, Muggia F, Demopoulos R, Weintroub M, et al: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York city and California. MMWR 1981;30:305-308.
22. Siminski J, Kidd P, Phillips GD, Collins C, Raghu G: Reversed helper/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1991;143:437-440.
23. Cano S, Capote F, Pereira A, Calderon E, Castillo J: Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest 1993; 104:376-381.
24. Jacobs JL, Libby DM, Winters RA, Gelmont DM, Fried ED, Hartman BJ, Laurence J: A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N Engl J Med 1991;324:246-250.
25. Baughman RP, Keely SP, Dohn MN, Stringer JR: The use of genetic markers to characterize transmission of Pneumocystis carinii. AIDS Pat Care STD 1997;11:131-138.
26. Bensousan T, Garo B, Islam S, Bourbigot B, Cledes J, Garre M: Possible transfer of Pneumocystis carinii between kidney transplant recipients. Lancet 1990;336:1066-11067.
27. Chave JP, David S, Wauters JP, Van Melle G, Francioli P: Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: A cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS 1991;5:927-932.
28. Hennequin C, Page B, Roux P, Legendre C, Kreis H: Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur J Clin Microbiol Infect Dis 1995;14:122-126.
29. Keely SP, Stringer JR, Baughman RP, Linke MJ, Walzer PD, Smulian AG: Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J Infect Dis 1995;172:595-598.
30. Keely SP, Baughman RP, Smulian AG, Dohn MN, Stringer JR: Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 1996;10:881-888.
31. Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, Glassroth J, Kvale PA, Rosen MJ, Reichman LB, Turner JR, Hopewell PC: Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997;155:60-66.
32. Baughman RP, Walzer PD (ed): Pneumocystis carinii Pneumonia Current Methods of Diagnosis. New York, Decker, 1994, pp 381-401.
33. Masur H, Lane HC, Kovacs JA, Allegra CJ, Edman JC: NIH conference. Pneumocystis pneumonia: From bench to clinic. Ann Intern Med 1989;111:813-826.
34. Gal AA, Klatt EC, Koss MN, Strigle SM, Boylen CT: The effectiveness of bronchoscopy in the diagnosis of Pneumocystis carinii and cytomegalovirus pulmonary infections in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1987;111:238-241.
35. Golden JA, Hollander H, Stulbarg MS, Gamsu G: Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia: A prospective study among patients with acquired immunodeficiency syndrome. Chest 1986;90:18-22.
36. Jules-Elysee KM, Stover DE, Zaman MB, Bernard EM, White DA: Aerosolized pentamidine: Effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990;112:750-757.
37. Hernandez Blasco L, Sanchez Hernandez IM, Villena Garrido V, de Miguel Poch E, Nunez Delgado M, Alfaro Abreu J: Safety of the transbronchial biopsy in outpatients. Chest 1991;99: 562-565.
38. Ahmad M, Livingston DR, Golish JA, Mehta AC, Wiedemann HP: The safety of outpatient transbronchial biopsy. Chest 1986;90:403-405.
39. Pereira W Jr, Kovnat DM, Snider GL: A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest 1978;73:813-816.
40. Griffiths MH, Kocjan G, Miller RF, Godfrey Faussett P: Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage. Thorax 1989;44:554-558.
41. Sepkowitz KA, Telzak EE, Gold JW, Bernard EM, Blum S, Carrow M, Dickmeyer M, Armstrong D: Pneumothorax in AIDS. Ann Intern Med 1991;114:455-459.
42. Baughman RP, Strohofer S, Colangelo G, Frame PT: Semiquantitative technique for estimating Pneumocystis carinii burden in the lung. J Clin Microbiol 1990;28:1425-1427.
43. Dohn MN, Baughman RP: Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis 1985;132:390-392.
44. Davis GS, Giancola MS, Costanza MC, Low RB: Analysis of sequential bronchoalveolar lavage samples from healthy human volunteers. Am Rev Respir Dis 1982;126:611-616.
45. Torrington KG, Finelli MR: Small volume bronchoalveolar lavage used in diagnosing Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1995;107:1013-1017.
46. Levine SJ, Kennedy D, Shelhamer JH, Kovacs A, Feuerstein IM, Gill VJ, Stock F, Solomon D, Boylen CT, Masur H, Ognibene FP: Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis. Am Rev Respir Dis 1992;146:838-843.
47. Read CA, Cerrone F, Busseniers AE, Waldhorn RE, Lavelle JP, Pierce PF: Differential lobe lavage for diagnosis of acute Pneumocystis carinii pneumonia in patients receiving prophylactic aerosolized pentamidine therapy. Chest 1993;103:1520-1523.
48. Yung RC, Weinacker AB, Steiger DJ, Miller TR, Stern EJ, Salmon CJ, Chemoff DN, Luistro MG, Kuntz S. Golden JA: Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993;148:1563-1566.
49. Baughman RP, Dohn MN, Shipley R, Buchsbaum JA, Frame PT: Increased Pneumocystis carinii recovery from the upper lobes in Pneumocystis pneumonia. The effect of aerosol pentamidine prophylaxis. Chest 1993;103:426-432.
50. Meduri GU, Stover DE, Greeno RA, Nash T, Zaman MB: Bilateral bronchoalveolar lavage in the diagnosis of opportunistic pulmonary infections. Chest 1991;100:1272-1276.
51. Wolfson JS, Waldron MA, Sierra LS. Blinded comparison of a direct immunofluorescent monoclonal antibody staining method and a Giemsa staining method for identification of Pneumocystis carinii in induced sputum and bronchoalveolar lavage specimens of patients infected with human immunodeficiency virus. J Clin Microbiol 1990;28:2136-2138.
52. Walker J, Conner G, Ho J, Hunt C, Pickering L: Giemsa staining for cysts and trophozoites of Pneumocystis carinii. J Clin Pathol 1989;42: 432-434.
53. Baughman RP, Strohofer S, Kim CK: Variation of differential cell counts of bronchoalveolar lavage fluid. Arch Pathol Lab Med 1986; 110:341-343.
54. Baughman RP, Strohofer SS, Clinton BA, Nickol AD, Frame PT: The use of an indirect fluorescent antibody test for detecting Pneumocystis carinii. Arch Pathol Lab Med 1989;113: 1062-1065.
55. Tollerud DJ, Wesseler TA, Kim CK, Baughman RP: Use of a rapid differential stain for identifying Pneumocystis carinii in bronchoalveolar lavage fluid. Diagnostic efficacy in patients with AIDS. Chest 1989;95:494-497.
56. Armbruster C, Pokieser L, Hassl A: Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol 1995;39:1089-1093.
57. Cregan P, Yamamoto A, Lum A, VanDer-Heide T, MacDonald M, Pulliam L: Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 1990;28:2432-2436.
58. Schumann GB, Swensen JJ: Comparison of Papanicolaou's stain with the Gomori methenamine silver (GMS) stain for the cytodiagnosis of Pneumocystis carinii in bronchoalveolar lavage (BAL) fluid. Am J Clin Pathol 1991;95:583-586.
59. Stanley MW, Henry MJ, Iber C: Foamy alveolar casts: Diagnostic specificity for Pneumocystis carinii pneumonia in bronchoalveolar lavage fluid cytology. Diagn Cytopathol 1988;4: 112-115.
60. Tregnago R, Xavier RG, Pereira RP, Prolla JC. The diagnosis of Pneumocystis carinii pneumonia by cytologic evaluation of Papanicolaou and Leishman-stained bronchoalveolar specimens in patients with the acquired immunodeficiency syndrome. Cytopathology 1993;4:77-84.
61. Pintozzi RL, Blecka LJ, Nanos S: Morphologic identification of Pneumocystis carinii. Acta Cytol 1979;23:35-39.
62. Homer KS, Wiley EL, Smith AL, McCollough L, Clark D, Nightingale SD, Vuitch F: Monoclonal antibody to Pneumocystis carinii. Comparison with silver stain in bronchial lavage specimens. Am J Clin Pathol 1992;97:619-624.
63. Paradis IL, Ross C, Dekker A, Dauber J: A comparison of modified methenamine silver and toluidine blue stains for the detection of Pneumocystis carinii in bronchoalveolar lavage specimens from immunosuppressed patients. Acta Cytol 1990;34:511-516.
64. Kovacs JA, Ng VL, Masur H, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE, et al: Diagnosis of Pneumocystis carinii pneumonia: Improved detection in sputum with use of monoclonal antibodies. N Engl J Med 1988;318:589-593.
65. Gosey LL, Howard RM, Witzbsky FG, Ognibene FP, Wu TC, Gill VJ, MacLowry JD: Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 1985;22:803-807.
66. Kim YK, Parulekar S, Yu PK, Pisani RJ, Smith TF, Anhalt JP: Evaluation of calcofluor white stain for detection of Pneumocystis carinii. Diagn Microbiol Infect Dis 1990;13:307-310.
67. Baselski VS, Robison MK, Pifer LW, Woods DR: Rapid detection of Pneumocystis carinii in bronchoalveolar lavage samples by using Cellufluor staining. J Clin Microbiol 1990;28:393-394.
68. Stratton N, Hryniewicki J, Aarnaes SL, Tan G, de la Maza LM, Peterson EM: Comparison of monoclonal antibody and calcofluor while stains for the detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol 1991;29:645-647.
69. Kovacs JA, Ng VL, Masur H, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE, Gill VJ: Diagnosis of Pneumocystis carinii pneumonia: Improved detection with use of monoclonal antibodies. N Engl J Med 1988;318:589-593.
70. Wakefield AE, Hopkin JM, Burns J, Hipkiss JB, Stewart TJ, Moxon ER: Cloning of DNA from Pneumocystis carinii. J Infect Dis 1988; 158:859-862.
71. Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, Hopkin JM: Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451-453.
72. Tamburrini E, Mencarini P, De Luca A, Maiuro G, Ventura G, Antinori A, Ammassari A, Visconti E, Ortona L, Siracusano A, et al: Diagnosis of Pneumocystis carinii pneumonia: Specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol 1993;38:449-453.
73. Moonens F, Liesnard C, Brancart F, Van Vooren JP, Serruys E: Rapid simple and nested polymerase chain reaction for the diagnosis of Pneumocystis carinii pneumonia. Scand J Infect Dis 1995;27:358-362.
74. Leibovitz E, Pollack H, Moore T, Papellas J, Gallo L, Krasinski K, Borkowsky W: Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus. J Clin Microbiol 1995;33:3004-3007.
75. Leigh TR, Wakefield AE, Peters SE, Hopkin JM, Collins JV: Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation 1992;54:468-470.
76. Masur H, Ognibene FP, Yarchoan R, Shelhammer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, Davey R, Polis M, Metcalf J, Baseler M, Wesley R, Gill VJ, Fauci AS, Lane HC: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection, Ann Intern Med 1989;111:223-231.
77. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A: The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N Engl J Med 1990;322:161-165.
78. Hughes WT, Kuhn S, Chaudhary S, et al: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987;316: 1627-1632.
79. Olsen SL, Renlund DG, O'Connell JB, Taylor DO, Lassetter JE, Eastburn TE, Hammond EH, Bristow MR: Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 1993;56:359-362.
80. Leoung GS, Feigel DW, Montgomery AB, Corkery K, Wardlaw L, et al: Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Prophylaxis Trial. N Engl J Med 1990;323: 769-775.
81. Nathan SD, Ross DJ, Zakowski P, Kass RM, Koerner SK: Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest 1994;105:417-420.
82. Hardy WD, Feinberg J, Finkelstein DM, Power ME, He W, Kaczka C, Frame PT, Holmes M, Waskin H, Fass RJ, Powderly WG, Steigbigel RT, Zuger A, Holzman RS: A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med 1992;327:1842-1848.
83. May T, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F, Saba J, Micoud M, Mouton Y, Canton P: Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: A prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectueuses. J Acquir Immune Defic Syndr 1994;7:457-462.
84. Haverkos HW: Assessment of therapy for Pneumocystis carinii pneumonia. Am J Med 1984;76:501-508.
85. Israel HL, Gottlieb JE, Schulman ES: Hypoxemia with normal chest roentgenogram due to Pneumocystis carinii pneumonia. Diagnostic errors due to low suspicion of AIDS. Chest 1997;92:857-859.
86. Kennedy CA, Goetz MB: Atypical roentgenographic manifestations of Pneumocystis carinii pneumonia. Arch Intern Med 1992;152:1390-1398.
87. Delorenzo LJ, Huang CT, Maguire GP, Stone DJ: Roentgenographic patteras of Pneumocystis carinii pneumonia in 104 patients with AIDS. Chest 1987;91:323-327.
88. Boiselle PM, Tocino I, Hooley RJ, Pumerantz AS, Selwyn PA, Neklesa VP, Lange RC: Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: Accuracy, distinguishing features, and mimics. J Thorac Imaging 1997;12:47-53.
89. Smith RL, Ripps CS, Lewis ML: Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia. Chest 1988; 93:987-992.
90. Speich R, Opravil M, Weber R, Hess T, Luethy R, Russi EW: Prospective evaluation of a prognostic score for Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1992;102: 1045-1048.
91. Zaman MK, White DA: Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Respir Dis 1988;137:796-800.
92. Grover SA, Coupal L, Suissa S, Szentveri T, Falutz J, Tsoukas C, Battista RN, Gilmore N: The clinical utility of serum lactate dehydrogenase in diagnosing Pneumocystis carinii pneumonia among hospitalized AIDS patients. Clin Invest Med 1992;15:309-317.
93. Stover DE, Greeno RA, Gagliardi AJ: The use of a simple exercise test for the diagnosis of Pneumocystis carinii pneumonia in patients with AIDS. Am Rev Respir Dis 1989;139: 1343-1346.
94. Tu JV, Biem HJ, Detsky AS: Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis. Am Rev Respir Dis 1993;148:370-377.
95. Sogin ML, Edman JC: A self-splicing intron in the small subunit rRNA gene of Pneumocystis carinii. Nucleic Acids Res 1989;17:5349-5359.
96. Liu Y, Leibowitz MJ: Variation and in vitro splicing of group I introns in rRNA genes of Pneumocystis carinii. Nucleic Acids Res 1993; 21:2415-2421.
97. Bigby TD, Margolskee D, Curtis JL, Michael PF, Sheppard D, Hadley WK, Hopewell PC: The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986;133:515-518.
98. Metersky ML, Aslenzadeh J, Stelmach P: A comparison of induced and expectorated sputum for the diagnosis of Pneumocystis carinii pneumonia. Chest 1998;113:1555-1559.
99. Wallace JM, Hansen NI, LaVange L, Glassroth J, Browdy BL, Rosen MJ, Kvale PA, Mangura BT, Reichman LB, Hopewell PC: Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997;155:72-80.
100. Horner RD, Bennett CL, Rodriguez D, Weinstein RA, Kessler HA, Dickinson GM, Johnson JL, Cohn SE, George WL, Gilman SC, Shapiro MF: Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995;152: 1435-1442.
101. Bennett CL, Horner RD, Weinstein RA, Kessler HA, Dickinson GM, Pitrak DL, Gilman SC, George WL, Cohn SE, Simberkoff MS, et al: Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami:1987-1990. J Infect Dis 1995; 172:312-315.
102. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J. Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
103. Murray JF: The white plague: Down and out, or up and coming? Am Rev Respir Dis 1989; 140:1788-1795.
104. Markowitz N, Hansen NI, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Wilcosky TC, Wallace JM, Rosen MJ, Reichman LB: Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med 1997;126: 123-132.
105. Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl Smit R: Mycobacterial infection in renal transplant recipients. Chest 1994; 106:435-439.
106. Jereb JA, Burwen DR, Dooley SW, Haas WH, Crawford JT, Geiter U, Edmond MB, Dowling JN, Shapiro R, Pasculle AW, et al: Nosocomial outbreak of tuberculosis in a renal transplant unit: Application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993;168:1219-1224.
107. Chin DP, Osmond D, Page Shafer K, Glassroth J. Rosen MJ, Reichman LB, Kvale PA, Wallace JM, Poole WK, Hopewell PC: Reliability of anergv skin testing in persons with HIV infection. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1996;153:1982-1984.
108. Daley CL, Hahn JA, Moss AR, Hopewell PC, Schecter GF: Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy. Am J Respir Crit Care Med 1998;157: 19-22.
109. Anonymous: Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations. Centers for Disease Control and Prevention. MMWR 1997; 46:1-10.
110. Narita M, Ashkin D, Hollender ES, Pitchenik AE: Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158:157-161.
111. Scott B, Schmid M, Nettleman MD: Early identification and isolation of inpatients at high risk for tuberculosis. Arch Intern Med 1994;154:326-330.
112. Cohen R, Muzaffar S, Capellan J, Azar H, Chinikamwala M: The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis. Chest 1996;109:420-423.
113. Long R, Maycher B, Scalcini M, Manfreda J: The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest 1991; 99:123-127.
114. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R: Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis 1997; 25:242-246.
115. Pozniak AL, MacLeod GA, Ndlovu D, Ross E. Mahari M, Weinberg J: Clinical and chest radiographic features of tuberculosis associated with human immunodeficiency virus in Zimbabwe. Am J Respir Crit Care Med 1995; 152:1558-1561.
116. Baughman RP, Dohn MN, Loudon RG, Frame PT: Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 1991;99:92-97.
117. Salzman SH, Schindel ML, Aranda CP, Smith RL, Lewis ML: The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992;102:143-146.
118. Charoenratanakul S, Dejsomritrutai W, Chaiprasert A: Diagnostic role of fiberoptic bronchoscopy in suspected smear negative pulmonary tuberculosis. Respir Med 1995; 89:621-623.
119. Wallace JM, Deutsch AL, Harrell JH, Moser KM: Bronchoscopy and transbronchial biopsy in evaluation of patients with suspected active tuberculosis. Am J Med 1981;70: 1189-1194.
120. Shah S, Miller A, Mastellone A, Kim K, Colaninno P, Hochstein L, D'Amato R: Rapid diagnosis of tuberculosis in various biopsy and body fluid specimens by the AMPLICOR Mycobacterium tuberculosis polymerase chain reaction test. Chest 1998;113:1190-1194.
121. Cohen RA, Muzaffar S, Schwartz D, Bashir S, Luke S, McGartland LP, Kaul K: Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 h of hospital admission. Am J Respir Crit Care Med 1998; 157:156-161.
122. Brugiere O, Vokurka M, Lecossier D, Mangiapan G, Amrane A, Milleron B, Mayaud C, Cadranel J, Hance AJ: Diagnosis of smear-negative pulmonary tuberculosis using sequence capture polymerase chain reaction. Am J Respir Crit Care Med 1997;155:1478-1481.
123. Condos R, McClune A, Rom WN, Schluger NW: Peripheral-blood-based PCR assay to identify patients with active pulmonary tuberculosis. Lancet 1996;347:1082-1085.
124. Rolfs A, Beige J, Finckh U, Kohler B, Schaberg T, Lokies J, Lode H: Amplification of Mycobacterium tuberculosis from peripheral blood. J Clin Microbiol 1995;33:3312-3314.
125. Huang TS, Liu YC, Lin HH, Huang WK, Cheng DL: Comparison of the Roche AMPLICOR MYCOBACTERIUM assay and Digene SHARP Signal System with in-house PCR and culture for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 1996;34:3092-3096.
126. Schluger NW, Kinney D, Harkin TJ, Rom WN: Clinical utility of the polymerase chain reaction in the diagnosis of infections due to Mycobacterium tuberculosis. Chest 1994;105: 1116-1121.
127. Choi YJ, Hu Y, Mahmood A: Clinical significance of a polymerase chain reaction assay for the detection of Mycobacterium tuberculosis. Am J Clin Pathol 1996;105:200-204.
128. Sobonya RE, Barbee RA, Wiens J, Trego D: Detection of fungi and other pathogens in immunocompromised patients by bronchoalveolar lavage in an area endemic for coccidioidomycosis. Chest 1990;97:1349-1355.
129. Wheat LJ, Slama TG, Zeckel M: Histoplasmosis in the acquired immunodeficiency syndrome. Am J Med 1985;78:203-210.
130. Salzman SH, Smith RL, Aranda CP: Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest 1988;93:916-921.
131. Cameron ML, Bartlett JA, Gallis HA, Waskin HA: Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Rev Infect Dis 1991;13:64-67.
132. Selik RM, Starcher ET, Curran JW: Opponunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1987;1:175-182.
133. Warr W, Bates JH, Stone A: The spectrum of pulmonary cryptococcosis. Ann Intern Med 1968;69:1109-1116.
134. Meyohas MC, Roux P, Bollens D, Chouaid C, Rozenbaum W, Meynard JL, Poirot JL, Frottier J, Mayaud C: Pulmonary cryptococcosis: Localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis 1995;21: 628-633.
135. Berenguer J, Allende MC, Lee JW, Garrett K, Lyman C, Ali NM, Bacher J, Pizzo PA, Walsh TJ: Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med 1995; 152:1079-1086.
136. Rhame FS: Prevention of nosocomial aspergillosis. J Hosp Infect 1991;18(suppl A):466-472.
137. Keating JJ, Rogers T, Petrou M, Cartledge JD, Woodrow D, Nelson M, Hawkins DA, Gazzard BG: Management of pulmonary aspergillosis in AIDS: An emerging clinical problem. J Clin Pathol 1994;47:805-809.
138. Tumbarello M, Ventura G, Caldarola G, Morace G, Cauda R, Ortona L: An emerging opportunistic infection in HIV patients: A retrospective analysis of 11 cases of pulmonary aspergillosis. Eur J Epidemiol 1993;9: 638-644.
139. Klapholz A, Salomon N, Perlman DC, Talavera W: Aspergillosis in the acquired immunodeficiency syndrome. Chest 1991;100: 1614-1618.
140. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA: Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324: 654-662.
141. von Eiff M, Roos N, Fegeler W, von Eiff C, Zuhlsdorf M, Glaser J, van de Loo J: Pulmonary fungal infections in immunocompromised patients: incidence and risk factors. Mycoses 1994;37:329-335.
142. el Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, del Bano D, Hernandez C, Jimenez de Anta MT: Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997;156:583-590.
143. Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP: Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 1993;72:137-142.
144. Hansen LA, Prakash UB, Colby TV: Pulmonary complications in diabetes mellitus. Mayo Clin Proc 1989;64:791-799.
145. Piliero PJ, Deresiewicz RL: Pulmonary zygomycosis after allogeneic bone marrow trans-plantation. South Med J 1995;88:1149-1152.
146. Rubin SA, Chaljub G, Winer Muram HT, Flicker S: Pulmonary zygomycosis: A radiographic and clinical spectrum. J Thorac Imaging 1992;7:85-90.
147. Pennington JE, ed: Respiratory Infections: Diagnosis and Management, ed 3. New York, Raven, 1994;25, Opportunistic fungal pneumonias: Aspergillus, Mucor, Candida, Torulopsis. p 533-549.
148. von Eiff M, Roos N, Schultze R, Hesse M, Zuhlsdorf M, van de Loo J: Pulmonary aspergillosis: Early diagnosis improves survival. Respiration 1995;62:341-347.
149. George RB, Jenkinson SG, Light RG: Fiberoptic bronchoscopy in the diagnosis of pulmonary fungal and nocardial infections. Chest 1978;73:33-36.
150. Baughman RP, Rhodes JC, Dohn MN, Henderson H, Frame PT: Detection of cryptococcal antigen in bronchoalveolar lavage fluid: A prospective study of diagnostic utility. Am Rev Respir Dis 1992;145:1226-1229.
151. Wheat LJ, Connolly Stringfield P, Williams B, Connolly K, Blair R, Bartlett M, Durkin M: Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulalum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis 1992; 145:1421-1424.
152. Machetti M, Feasi M, Mordini N, Van Lint MT, Bacigalupo A, Latge JP, Sarfati J, Viscoli C: Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients. Bone Marrow Transplant 1998;21:917-921.
153. Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AV, Meis JF: Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997;25: 86-89.
154. Verweij PE, Latge JP, Rijs AJ, Melchers WJ, De Pauw BE, Hoogkamp Korstanje JA, Meis JF: Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995;33:3150-3153.
155. Bretagne S, Costa JM, Marmorat Khuong A, Poron F, Cordonnier C, Vidaud M, Fleury Feith J: Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995;33: 1164-1168.
156. Tang CM, Holden DW, Aufauvre Brown A, Cohen J: The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Respir Dis 1993;148:1313-1317.
157. von Eiff M, Roos N, Fegeler W, von Eiff C, Schultze R, Hesse M, Zuhlsdorf M, van de Loo J: Hospital-acquired candida and aspergillus pneumonia - diagnostic approaches and clinical findings. J Hosp Infect 1996;32: 17-28.
158. Diederich S, Scadeng M, Dennis C, Stewart S, Flower CD: Aspergillus infection of the respiratory tract after lung transplantation: Chest radiographic and CT findings. Eur Radiol 1998;8:306-312.
159. Blum U, Windfuhr M, Buitrago Tellez C, Sigmund G, Herbst EW, Langer M: Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994;106:1156-1161.
160. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona. Spain. N Engl J Med 1995;333:474-480.
161. Murray JF, Garay SM, Hopewell PC, Mills J, Snider GL, Stover DE: Pulmonary complications of the acquired immunodeficiency syndrome: An update. Am Rev Respir Dis 1987; 135:504-509.
162. Wallace JM, Rao AV, Glassroth J, Hansen NI, Rosen MJ, Arakaki C, Kvale PA, Reichman LB, Hopewell PC: Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. Am Rev Respir Dis 1993;148:1523-1529.
163. Jimenez ML Aspa J, Padilla B, Ancochea J, Gonzalez A, Fraga J, Santos I, Martinez R, Gomez Herruz P, Lopez Brea M: Fiberoptic bronchoscopic diagnosis of pulmonary disease in 151 HIV-infected patients with pneumonitis. Eur J Clin Microbiol Infect Dis 1991;10:491-1496.
164. Chan CC, Abi Saleh WJ, Arroliga AC, Stillwell PC, Kirby TJ, Gordon SM, Petras RE, Mehta AC: Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 1996;15:196-205
165. Ip MS, Yuen KY, Chiu EK, Chan JC, Lam WK, Chan TK: Pulmonary infections in bone marrow transplantation: The Hong Kong experience. Respiration 1995;62:80-83.
166. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC: Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333:845-851.
167. England AC, Fraser DW, Plikaytis BD, Tsai TF, Storch G, Broome CV: Sporadic legionellosis in the United States: The first thousand cases. Ann Intern Med 1981;94:164-170.
168. Bangsborg JM, Jensen BN, Friis-Moller A, Bruun B: Legionellosis in patients with HIV infection. Infection 1990;18:342-346.
169. Blatt SP, Dolan MJ, Hendrix CW, Melcher GP: Legionnaires' disease in human immunodeficiency virus-infected patients: Eight cases and review. Clin Infect Dis 1994;18: 227-232.
170. Edelstein PH, Meyer RD, Pennington JE, (eds): Respiratory Infections: Diagnosis and Management, cd 3. New York, Raven. 1994; 22, Legionella pneumonias pp 455-484.
171. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL: Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987;155:855-861.
172. Kahn FW, Jones JM: Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987;155:862-869.
173. Kahn FW, Jones JM: Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory. J Clin Microbiol 1988;26:1150-1155.
174. Cantral DE, Tape TG, Reed EC, Spurzem JR, Rennard SI, Thompson AB: Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med 1993;95:601-607.
175. Arlotti M, Zoboli G, Moscatelli GL, Magnani G, Maserati R, Borghi V, Andreoni M, Libanore M, Bonazzi L, Piscina A, Ciammarughi R: Rhodococcus equi infection in HIV-positive subjects: A retrospective analysis of 24 cases. Scand J Infect Dis 1996;28:463-467.
176. Scott MA, Graham BS, Verrall R, Dixon R, Schaffner W, Tham KT: Rhodococcus equi -an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol 1995; 103:649-655.
177. Muntaner L, Leyes M, Payeras A, Herrera M, Gutierrez A: Radiologic features of Rhodococcus equi pneumonia in AIDS. Eur J Radiol 1997;24:66-70.
178. Munoz P, Burillo A, Palomo J, Rodriguez Creixems M, Bouza E: Rhodococcus equi infection in transplant recipients: Case report and review of the literature. Transplantation 1998;65:449-453.
179. Colangelo G, Baughman RP, Dohn MN, Frame PT: Follow-up bronchoalveolar lavage in AIDS patients with Pneumocystis carinii pneumonia. Pneumocystis carinii burden predicts early relapse. Am Rev Respir Dis 1991; 143:1067-1071.